Patrick Griffin retweeted
Our paper is out in @NatureAging. We looked for factors that make old cells' gene expression young without erasing their identity. SRSF1 came out as a promising rejuvenation target that reduced aging hallmarks in human cells and extended median lifespan of aged mice by 14%.
1/4

ALT Watercolor-style graphic of two overlapping cells split by a curved diagonal. On the left, a muted gray cell with a dark nucleus and faint white circuit traces. On the right, the same form in luminous blue, its circuitry lit up. Short dashes standing for RNA transcripts scatter loosely in gray on the left and fan outward in blue and pale green arcs on the right. Art by Helen H. Wang.
Patrick Griffin retweeted
Today we announced interim data from our first-in-human, Phase 1 clinical trial evaluating our lead program in optic neuropathies, showing it was well-tolerated by 3 participants with glaucoma.
Read more about our safety & visual field observations here:bit.ly/4ASWq0p
Patrick Griffin retweeted
1/ Excited to share our new preprint from a joint collaboration between @JswLab + @Bruce_Ksander!
Aging is marked by a progressive loss of resilience to stress. Can we systematically search the human ORFome for genes that make vulnerable cells more resilient?
Performing such a genome-scale ORF screen led us to NKX2-5—a heart transcription factor we engineered to restore vision, and improve health in aged mice.
A breakdown🧵
🔗 doi.org/10.64898/2026.09.29.…
Patrick Griffin retweeted
Infinite Epigenetics & True Diagnostics acquire @sinclairfriends lab spin-out, Tally, giving them access to DNAme IP to help bring down costs & accelerate epigenetics-informed health care
Congrats to @L_Catterton, @melanie_goldey, @patrick_griffN, @gladyshev_lab & the entire team! 👏
Patrick Griffin retweeted
It takes two (transcription factors) to tango
Transcription factor collaboration enables precise T cell state engineering
tinyurl.com/tcelltfs
Excited to share our preprint with @JD_Buenrostro, @cgersbach, and an incredible team of collaborators as part of @IGVFConsortium
🧵
Patrick Griffin retweeted
Excited to share my postdoc work with @JD_Buenrostro now out in @Nature!
"Epigenetic memory of colitis promotes tumour growth"
nature.com/articles/s41586-0…
We wanted to understand how transient inflammation can create a long-lived increase in cancer risk, even after full recovery 🧵
Patrick Griffin retweeted
First test of partial epigenetic reprogramming to reverse aging for two eye conditions (glaucoma and NAION) gets FDA go ahead
@lifebiosciences Based on 2020 @Nature paper pubmed.ncbi.nlm.nih.gov/3326…
endpoints.news/exclusive-fda…
Patrick Griffin retweeted
Huge thanks to all co-authors and the inimitable
@JD_Buenrostro for supporting this new direction - I got to think about evolution, engineering, chromatin biophysics, and modeling during the course of this project. For more, check out the preprint: biorxiv.org/content/10.1101/…
Patrick Griffin retweeted
Excited to share a short article I wrote describing: Slide-tags - which enables spatial single-nucleus sequencing, allowing us to dive deeper into the complexity of tissue organization. Grateful for the amazing team and support from @insitubiology and @macosko! #ToolsOfTheTrade
Slide-tags enables spatial single-nucleus sequencing
go.nature.com/48x06XP #ToolsOfTheTrade by Andrew J. C. Russell @AndyRusss @broadinstitute @insitubiology @HSCRB
Patrick Griffin retweeted
The latest LLLM (large language of life) foundation model, with state-of-the art chronological age estimation, prediction of outcomes, and performance across different datasets and conditions
Excited to share CpGPT, a new foundation model for DNA methylation, crafted to understand the 'language' of epigenetics! 🧬🤖
What’s CpGPT?
CpGPT is a transformer model pre-trained on CpGCorpus, a huge dataset of public DNA methylation info. By integrating sequence, positional, and epigenetic data, it captures complex epigenetic interactions from even a small part of the methylome.
📄 Preprint: biorxiv.org/cgi/content/shor…
Why CpGPT?
DNA methylation is key for gene expression and chromatin structuring, with CpG sites often varying in diseases like cancer and aging. Here’s what sets CpGPT apart:
✨ CpGPT Highlights:
🔧 Deep Pretraining: Trained on over 100K samples from 1,500+ studies, covering 1M+ CpG sites.
🗺️ Zero-Shot Skills: CpGPT imputes methylation from minimal data, mapping different Illumina arrays to a common reference.
🐭 Cross-Mammalian Reach: When fine-tuned, CpGPT accurately imputes methylation in new mammalian species.
📈 Strong Performance: Fine-tuned CpGPT ranks 2nd overall and 1st on the public leaderboard for age and mortality prediction in the Biomarkers of Aging Challenge.
Special shoutout to Lucas (@ollimacsacul) for his outstanding leadership on this project! Big thanks as well to all the co-authors (@rv_sehgal, @prof_horvath, etc.) for their dedication and swift feedback throughout.
We're committed to open science and are actively preparing the code. Expect the full code and model weights to be available soon—likely within the next few weeks!
Patrick Griffin retweeted
Introducing IN SITU GENOME SEQUENCING, a new technology to resolve DNA sequence🧬 and structure🔬
A team effort with @Andrew_C_Payne, @PaulReginato, @eboyden3, @JD_Buenrostro, and Fei Chen
science.sciencemag.org/conte…
This is how it works: (1/8)
Patrick Griffin retweeted
Thrilled to see our ExIGS tool featured! A true testament to the power of collaboration. Huge congrats to the team for their hard work! 🧬@ajaylabade31 @z_chiang @CarolineComenho nature.com/articles/d41586-0…
Patrick Griffin retweeted
Grades of DNA methylation as the basis of epigenetic cell memory... must-read.
biorxiv.org/content/10.1101/…
Patrick Griffin retweeted
T cells become exhausted and fail to control tumors in cancer patients. What if we could replicate T cell exhaustion in vitro and uncover the gene regulatory network driving exhaustion, enabling immuno-oncology drug discovery? With AstraZeneca, the Buenrostro lab addresses this gap (biorxiv.org/content/10.1101/…):
Patrick Griffin retweeted
Study Proposes Framework to Standardize Biomarkers of Aging and Accelerate Clinical Use @jpoganik
Read more: buff.ly/3OMHMBo
Patrick Griffin retweeted
We are recruiting postdoctoral fellows in neurobiology and development to complement our group specializing in genomic technologies, epigenetics and machine learning. projects are very well funded and we are interested in co-mentorship. Please DM if interested in hearing more!
Patrick Griffin retweeted
Our latest paper is out - a new method called "TIME-Seq" to measure biological age for just a few dollars. Great work Patrick Griffin! @NatureAging Free download rdcu.be/dvDfc
Patrick Griffin retweeted
Can we reverse aging?
7 yrs ago, Ocampo et al. showed that partial reprogramming can ameliorate aging hallmarks. But, OSKM induction has safety limitations & no new factors have emerged since. Here, biorxiv.org/content/10.1101/… we used 🧬 screens to find new rejuvenation factors🧵1/8
Patrick Griffin retweeted
Delving into our newly released result, a thread:
Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma: A year-long functional tracking of in vivo partial reprogramming demonstrates safety and efficacy. Work from @margaretekarg @YuanchengLu @davidasinclair @bruce_ksander liebertpub.com/doi/10.1089/c…
Patrick Griffin retweeted
Can we shield the epigenome from age-related changes, much like how SIRT6 defends the genome? Using a CRISPRi screening approach, @XiaoTianPhD seeks to identify genes involved in maintaining epigenome stability. His new lab @sbpdiscovery is recruiting for various roles!





























